166 related articles for article (PubMed ID: 21471746)
1. Linezolid and clindamycin improve the outcome of severe, necrotizing pneumonia due to community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA).
Soavi L; Signorini L; Stellini R; Acquarolo A; Fiorese B; Magri S; Pantosti A; Suter F; Carori G
Infez Med; 2011 Mar; 19(1):42-4. PubMed ID: 21471746
[TBL] [Abstract][Full Text] [Related]
2. How important is methicillin-resistant Staphylococcus aureus as a cause of community-acquired pneumonia and what is best antimicrobial therapy?
Wunderink RG
Infect Dis Clin North Am; 2013 Mar; 27(1):177-88. PubMed ID: 23398873
[TBL] [Abstract][Full Text] [Related]
3. Community-acquired necrotizing pneumonia caused by methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin in a Chinese teenager: case report and literature review.
Chen J; Luo Y; Zhang S; Liang Z; Wang Y; Zhang Y; Zhou G; Jia Y; Chen L; She D
Int J Infect Dis; 2014 Sep; 26():17-21. PubMed ID: 24980464
[TBL] [Abstract][Full Text] [Related]
4. Expanded clinical presentation of community-acquired methicillin-resistant Staphylococcus aureus pneumonia.
Lobo LJ; Reed KD; Wunderink RG
Chest; 2010 Jul; 138(1):130-6. PubMed ID: 20173050
[TBL] [Abstract][Full Text] [Related]
5. [Necrotizing pneumonia by community-acquired, methicillin-resistant Staphylococcus aureus in Colombia].
Gómez CH; Perilla AM; González C; Valderrama SL; Vanegas N; Chavarro B; Triana LC; Támara JR; Alvarez CA
Biomedica; 2009 Dec; 29(4):523-30. PubMed ID: 20440450
[TBL] [Abstract][Full Text] [Related]
6. In vivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice.
Guo Y; Ramos RI; Cho JS; Donegan NP; Cheung AL; Miller LS
Antimicrob Agents Chemother; 2013 Feb; 57(2):855-63. PubMed ID: 23208713
[TBL] [Abstract][Full Text] [Related]
7. [A case of community-acquired MRSA (CA-MRSA) sepsis complicated by meningoencephalitis and cerebral abscess, successfully treated with linezolid].
Gattuso G; Palvarini L; Tomasoni D; Ferri F; Scalzini A
Infez Med; 2009 Dec; 17(4):244-8. PubMed ID: 20046106
[TBL] [Abstract][Full Text] [Related]
8. Simulated antibiotic exposures in an in vitro hollow-fiber infection model influence toxin gene expression and production in community-associated methicillin-resistant Staphylococcus aureus strain MW2.
Pichereau S; Pantrangi M; Couet W; Badiou C; Lina G; Shukla SK; Rose WE
Antimicrob Agents Chemother; 2012 Jan; 56(1):140-7. PubMed ID: 22064533
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus pneumonia with high doses of linezolid administered in continuous infusion.
Álvarez-Lerma F; Muñoz-Bermúdez R; Samper-Sánchez MA; Gracia Arnilla MP; Grau S; Luque S
Med Intensiva; 2017; 41(1):56-59. PubMed ID: 27269810
[No Abstract] [Full Text] [Related]
10. In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates.
Vidaillac C; Parra-Ruiz J; Winterfield P; Rybak MJ
Int J Antimicrob Agents; 2011 Oct; 38(4):301-6. PubMed ID: 21764263
[TBL] [Abstract][Full Text] [Related]
11. [CA-MRSA].
Iwata K
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():436-40. PubMed ID: 17455658
[No Abstract] [Full Text] [Related]
12. Activity of moxifloxacin against intracellular community-acquired methicillin-resistant Staphylococcus aureus: comparison with clindamycin, linezolid and co-trimoxazole and attempt at defining an intracellular susceptibility breakpoint.
Lemaire S; Kosowska-Shick K; Appelbaum PC; Glupczynski Y; Van Bambeke F; Tulkens PM
J Antimicrob Chemother; 2011 Mar; 66(3):596-607. PubMed ID: 21186193
[TBL] [Abstract][Full Text] [Related]
13. Comparative effectiveness of linezolid and vancomycin among a national veterans affairs cohort with methicillin-resistant Staphylococcus aureus pneumonia.
Caffrey AR; Morrill HJ; Puzniak LA; Laplante KL
Pharmacotherapy; 2014 May; 34(5):473-80. PubMed ID: 24420846
[TBL] [Abstract][Full Text] [Related]
14. [Conservative treatment of a hip prosthesis infection due to methicillin-resistant Staphylococcus aureus using prolonged antibiotic therapy based on linezolid followed by daptomycin].
Grossi O; Talarmin JP; Boutoille D; Frioux R; Corvec S; Raffi F
Med Mal Infect; 2008 Dec; 38 Spec No 2():10-2. PubMed ID: 19185203
[No Abstract] [Full Text] [Related]
15. Effects of linezolid on suppressing in vivo production of staphylococcal toxins and improving survival outcomes in a rabbit model of methicillin-resistant Staphylococcus aureus necrotizing pneumonia.
Diep BA; Afasizheva A; Le HN; Kajikawa O; Matute-Bello G; Tkaczyk C; Sellman B; Badiou C; Lina G; Chambers HF
J Infect Dis; 2013 Jul; 208(1):75-82. PubMed ID: 23532096
[TBL] [Abstract][Full Text] [Related]
16. What is MRSA?
Hewett ML
JAAPA; 2010 Sep; 23(9):59. PubMed ID: 20845657
[No Abstract] [Full Text] [Related]
17. Methicillin-resistant Staphylococcus aureus pneumonia in adults.
Woods C; Colice G
Expert Rev Respir Med; 2014 Oct; 8(5):641-51. PubMed ID: 25030040
[TBL] [Abstract][Full Text] [Related]
18. Community-acquired methicillin-resistant Staphylococcus aureus and Lemierre syndrome.
Bilal M; Cleveland KO; Gelfand MS
Am J Med Sci; 2009 Oct; 338(4):326-7. PubMed ID: 19701080
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial agents in treatment of MRSA infections.
Johnson MD; Decker CF
Dis Mon; 2008 Dec; 54(12):793-800. PubMed ID: 18996282
[No Abstract] [Full Text] [Related]
20. Unilateral lymphadenitis caused by community-associated methicillin-resistant Staphylococcus aureus ST834 strain.
Eda H; Arakawa Y; Yoshida T; Ogasawara F; Kojima K; Nakaminami H; Yamagishi Y
J Infect Chemother; 2024 Jul; 30(7):651-654. PubMed ID: 38097041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
